Li ZH - Search Results

1

Isoforms of human O-GlcNAcase show distinct catalytic efficiencies.

Li J, Huang CL, Zhang LW, Lin L, Li ZH, Zhang FW, Wang P. Li J, et al. Among authors: li zh. Biochemistry (Mosc). 2010 Jul;75(7):938-43. doi: 10.1134/s0006297910070175. Biochemistry (Mosc). 2010. PMID: 20673219 Free article.

2

The histone deacetylase inhibitor suberoylanilide hydroxamic acid induces growth inhibition and enhances taxol-induced cell death in breast cancer.

Shi YK, Li ZH, Han XQ, Yi JH, Wang ZH, Hou JL, Feng CR, Fang QH, Wang HH, Zhang PF, Wang FS, Shen J, Wang P. Shi YK, et al. Among authors: li zh. Cancer Chemother Pharmacol. 2010 Nov;66(6):1131-40. doi: 10.1007/s00280-010-1455-1. Epub 2010 Sep 14. Cancer Chemother Pharmacol. 2010. PMID: 20838997

3

Design and synthesis of O-GlcNAcase inhibitors via 'click chemistry' and biological evaluations.

Li T, Guo L, Zhang Y, Wang J, Li Z, Lin L, Zhang Z, Li L, Lin J, Zhao W, Li J, Wang PG. Li T, et al. Carbohydr Res. 2011 Jul 1;346(9):1083-92. doi: 10.1016/j.carres.2011.03.026. Epub 2011 Mar 21. Carbohydr Res. 2011. PMID: 21514574

4

Structure-based optimization of click-based histone deacetylase inhibitors.

Hou J, Feng C, Li Z, Fang Q, Wang H, Gu G, Shi Y, Liu P, Xu F, Yin Z, Shen J, Wang P. Hou J, et al. Eur J Med Chem. 2011 Aug;46(8):3190-200. doi: 10.1016/j.ejmech.2011.04.027. Epub 2011 Apr 29. Eur J Med Chem. 2011. PMID: 21621883

5

[Antigen selection, optimized expression and polyclonal antibody preparation of O-GlcNAcase].

Lin L, Li G, Li Z, Xu Y, Tian G, Li J, Liu Y. Lin L, et al. Sheng Wu Gong Cheng Xue Bao. 2011 Aug;27(8):1183-90. Sheng Wu Gong Cheng Xue Bao. 2011. PMID: 22097807 Chinese.

6

Discovery and structural insight of a highly selective protein kinase inhibitor hit through click chemistry.

Gu G, Wang H, Liu P, Fu C, Li Z, Cao X, Li Y, Fang Q, Xu F, Shen J, Wang PG. Gu G, et al. Chem Commun (Camb). 2012 Mar 14;48(22):2788-90. doi: 10.1039/c1cc15851a. Epub 2012 Feb 8. Chem Commun (Camb). 2012. PMID: 22314408

7

Identification of a specific inhibitor of nOGA - a caspase-3 cleaved O-GlcNAcase variant during apoptosis.

Li J, Li Z, Li T, Lin L, Zhang Y, Guo L, Xu Y, Zhao W, Wang P. Li J, et al. Biochemistry (Mosc). 2012 Feb;77(2):194-200. doi: 10.1134/S0006297912020113. Biochemistry (Mosc). 2012. PMID: 22348480

8

Discovery and extensive in vitro evaluations of NK-HDAC-1: a chiral histone deacetylase inhibitor as a promising lead.

Hou J, Li Z, Fang Q, Feng C, Zhang H, Guo W, Wang H, Gu G, Tian Y, Liu P, Liu R, Lin J, Shi YK, Yin Z, Shen J, Wang PG. Hou J, et al. J Med Chem. 2012 Apr 12;55(7):3066-75. doi: 10.1021/jm201496g. Epub 2012 Mar 30. J Med Chem. 2012. PMID: 22435669

9

Elevation of cellular O-GlcNAcylation level by a potent and selective O-GlcNAcase inhibitor based on tetrahydroimidazopyridine scaffold.

Li T, Li Z, Li J, Wang J, Guo L, Wang PG, Zhao W. Li T, et al. Bioorg Med Chem Lett. 2012 Nov 15;22(22):6854-7. doi: 10.1016/j.bmcl.2012.09.042. Epub 2012 Sep 23. Bioorg Med Chem Lett. 2012. PMID: 23058883

10

New insights into the pharmacological chaperone activity of c2-substituted glucoimidazoles for the treatment of Gaucher disease.

Li Z, Li T, Dai S, Xie X, Ma X, Zhao W, Zhang W, Li J, Wang PG. Li Z, et al. Chembiochem. 2013 Jul 8;14(10):1239-47. doi: 10.1002/cbic.201300197. Epub 2013 Jun 14. Chembiochem. 2013. PMID: 23775891

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,502 results

Search Page

Filters